Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Net Income (2018 - 2025)

TransMedics (TMDX) has 8 years of Net Income data on record, last reported at -$68.1 million in Q4 2025.

  • For Q4 2025, Net Income fell 139.35% year-over-year to -$68.1 million; the TTM value through Dec 2025 reached $10.5 million, up 7090.41%, while the annual FY2025 figure was $189.2 million, 129456.16% up from the prior year.
  • Net Income reached -$68.1 million in Q4 2025 per TMDX's latest filing, down from $19.8 million in the prior quarter.
  • Across five years, Net Income topped out at $33.1 million in Q2 2025 and bottomed at -$68.1 million in Q4 2025.
  • Average Net Income over 5 years is -$1.6 million, with a median of -$5.0 million recorded in 2022.
  • Peak YoY movement for Net Income: plummeted 239.74% in 2023, then skyrocketed 1318.18% in 2024.
  • A 5-year view of Net Income shows it stood at -$12.7 million in 2021, then soared by 334.42% to $29.7 million in 2022, then rose by 4.82% to $31.1 million in 2023, then crashed by 191.39% to -$28.4 million in 2024, then tumbled by 139.35% to -$68.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$68.1 million in Q4 2025, $19.8 million in Q3 2025, and $33.1 million in Q2 2025.